13F reference period
Q2 2026
Security Snapshot
ImageneBio, Inc. - Common Stock, $0.001 par value (IMA) Institutional Ownership
CUSIP: 45175G207
13F Institutional Holders and Ownership History from Q3 2025 to Q2 2026
Institutions Reporting
35
Shares (Excl. Options)
6.23M
Full value: 6,234,663 · shares · 30 Jun 2026Price
$5.90
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.001 par value
- Symbol
- IMA on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 6,234,663
- Total 13F value
- $36,791,065
- Portfolio coverage rank
- 0%
- Share change
- +878,708
- Value change
- +$5,259,589
- Number of holders
- 35
- Shares outstanding
- 11,400,475
- SEC-reported price per share
- $4.09
- Insider filing price
- $4.09
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- IMA - ImageneBio, Inc. - Common Stock, $0.001 par value is tracked under CUSIP 45175G207.
- 35 institutions reported positions in Q2 2026.
- 8 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 39 to 35 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$26.77M
Full value: $26,770,536 · USD · 31 Mar 2026.$36.79M
Full value: $36,791,065 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 35 institutions filings for Q2 2026.
Security key
45175G207
13F reference period
Q2 2026
13F holders
35
13D/G owners
8
CIK / CUSIP context first
Open Q2 2026 holders
IMA full holder history
ImageneBio, Inc. SEC filings
ImageneBio, Inc. company facts
ImageneBio, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 45175G207:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
8
Security
IMA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 13% | $7,475,225 | 1,495,045 | ORBIMED ADVISORS LLC | 14 Apr 2026 | |||
| Trails Edge Capital Partners, LP | 9.9% | $5,882,360 | 1,176,472 | Trails Edge Capital Partners, LP | 14 Apr 2026 | |||
| BIOTECHNOLOGY VALUE FUND L P | 9.9% | 0% | $6,896,033 | +$113,921 | 1,128,647 | +1.7% | BVF PARTNERS L P/IL | 30 Jun 2026 |
| Blue Owl Capital Holdings LP | 8.5% | +16% | $5,803,989 | +$820,090 | 959,337 | +16% | Blue Owl Capital Holdings LP | 31 Mar 2026 |
| Omega Fund VI, L.P. | 8.4% | $4,681,110 | 936,222 | Otello Stampacchia | 14 Apr 2026 | |||
| Funicular Funds, LP | 5.8% | $4,211,322 | 643,933 | Funicular Funds, LP | 29 Dec 2025 | |||
| Atlas Venture Fund X, L.P. | 2.1% | 241,800 | Atlas Venture Fund X, L.P. | 25 Jul 2025 | ||||
| BML Investment Partners, L.P. | 1.9% | 220,832 | Leonard Braden Michael | 25 Jul 2025 |
As of 30 Jun 2026,
35
institutional investors reported holding
shares of
ImageneBio, Inc. - Common Stock, $0.001 par value (IMA).
This represents
55%
of the company’s total
outstanding shares.
6.23M
Full value: 6,234,663 · shares · 30 Jun 202611.4M
Full value: 11,400,475 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
54%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BVF INC/IL | 9.7% | 1,110,002 | 0% | 0.17% | $6,549,012 |
| Blue Owl Capital Holdings LP | 8% | 917,692 | -4.3% | 0.82% | $5,414,383 |
| ORBIMED ADVISORS LLC | 8% | 909,269 | +140% | 0.1% | $5,364,687 |
| Cable Car Capital, LP | 6.9% | 781,599 | +3.6% | 0.1% | $4,611,434 |
| Omega Fund Management, LLC | 4% | 455,361 | 0% | 1.4% | $2,686,630 |
| RTW INVESTMENTS, LP | 2.9% | 334,445 | 0% | 0.02% | $1,973,226 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.8% | 320,518 | -1.4% | 0% | $1,891,056 |
| Trails Edge Capital Partners, LP | 2.5% | 282,004 | 0.26% | $1,663,824 | |
| BML Capital Management, LLC | 1.8% | 200,730 | 0% | 0.68% | $1,184,307 |
| Monashee Investment Management LLC | 1.7% | 192,344 | 1.9% | $1,134,830 | |
| BlackRock, Inc. | 1.2% | 135,090 | +4.5% | 0% | $797,030 |
| RENAISSANCE TECHNOLOGIES LLC | 0.76% | 86,930 | +6.4% | 0% | $512,887 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.58% | 66,666 | 0% | 0% | $393,329 |
| CITADEL ADVISORS LLC | 0.49% | 55,610 | -55% | 0% | $328,099 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.47% | 53,512 | -11% | 0% | $315,755 |
| NEA Management Company, LLC | 0.44% | 50,005 | 0% | 0.02% | $295,030 |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 0.44% | 50,000 | +67% | 0.23% | $295,000 |
| HSBC HOLDINGS PLC | 0.3% | 34,228 | -1.9% | 0% | $208,449 |
| Sofinnova Investments, Inc. | 0.28% | 31,884 | 0% | 0.01% | $188,116 |
| VANGUARD FIDUCIARY TRUST CO | 0.24% | 27,475 | +0.69% | 0% | $162,103 |
| Rangeley Capital, LLC | 0.18% | 20,090 | -38% | 0.12% | $118,531 |
| TWO SIGMA INVESTMENTS, LP | 0.17% | 19,900 | 0% | $117,410 | |
| Aldebaran Capital, LLC | 0.16% | 18,124 | -2.4% | 0.08% | $106,932 |
| Shay Capital LLC | 0.16% | 18,080 | -5.5% | 0.01% | $106,672 |
| MORGAN STANLEY | 0.15% | 16,678 | -9.1% | 0% | $98,400 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
4
Headline period
Q2 2026
Rows shown
1-4 of 4